EyePoint Pharmaceuticals vs Re-Vana Therapeutics

EyePoint Pharmaceuticals logo

EyePoint Pharmaceuticals

Delivering Innovation to the Eye™ NOW HIRING!

190 employees · est. 1987

VS
Re-Vana Therapeutics logo

Re-Vana Therapeutics

To advance the quality of care for patients suffering from sight-threatening diseases

24 employees · est. 2016 · United Kingdom

EyePoint Pharmaceuticals is the older company (1987 vs 2016); EyePoint Pharmaceuticals is the larger of the two.

Side-by-Side Comparison

EyePoint Pharmaceuticals Re-Vana Therapeutics
Founded
1987 older 2016
Headquarters
Not tracked yet United Kingdom
Employees
190 larger 24
Industry
Biotechnology, Health Care, Pharmaceutical Health Care, Health and Wellness, Marketing
Funding Stage
Post-IPO Equity Series A
Total Funding
$653.80M $14.45M
Funding Rounds
10 4
Taxonomy
Not tracked yet Ocular PharmaceuticalsDrug Delivery TechnologyPhotocrosslinked TechnologiesIntravitreal AdministrationTopical Drug DeliveryBiologics +9
Website
eyepointpharma.com revanatx.com
EyePoint Pharmaceuticals logo

About EyePoint Pharmaceuticals

EyePoint Pharmaceuticals (Nasdaq: EYPT) is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company's pipeline leverages its proprietary Durasert® technology for sustained intraocular drug delivery...

Re-Vana Therapeutics logo

About Re-Vana Therapeutics

Re-Vana Therapeutics, founded in 2016 and headquartered in the United Kingdom, is committed to improving patient care for sight-threatening diseases through innovative drug delivery systems. The company operates within the Health Care and Health and Wellness sectors. Its pioneering approach address...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches EyePoint Pharmaceuticals and Re-Vana Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when EyePoint Pharmaceuticals or Re-Vana Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

EyePoint Pharmaceuticals was founded in 1987, with 190 employees. EyePoint Pharmaceuticals (Nasdaq: EYPT) is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Compa. Re-Vana Therapeutics was founded in 2016, based in United Kingdom, with 24 employees. Re-Vana Therapeutics, founded in 2016 and headquartered in the United Kingdom, is committed to improving patient care for sight-threatening diseases through innovative drug delivery systems. The compa.
EyePoint Pharmaceuticals has raised $653.80M and Re-Vana Therapeutics $14.45M. Latest stage: EyePoint Pharmaceuticals Post-IPO Equity, Re-Vana Therapeutics Series A.
Both work in Health Care.

Compare EyePoint Pharmaceuticals with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at EyePoint Pharmaceuticals on 13 Sep 2024, and Re-Vana Therapeutics on 13 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes